标题：Author Correction: MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway
摘要：Correction to:
Scientific Reports 10.1038/srep40384, published online 11 January 2017
This Article contains an error in Figure 4D, where the image for the blank condition was inadvertently duplicated for the NC panel. The correct Figure
4 and its accompanying legend appear below.
Figure 4
The A549 cell line and cells transfected with negative control (NC) and the miR-488 mimic were used in the following assays. Cell viability (
a) was tested with an MTT assay, and colony formation (
b) was measured with crystal violet staining. All these showed that miR-488 could inhibit the proliferation of A549 cells. Wound healing (
c) and transwell assays with Matrigel (
d) were tested in A549 cells with miR-488 overexpression. The percent of wounds closed or number of cells migrating through the membrane were counted and are compared in the diagrams. The cell cycle (
e) was evaluated with flow cytometry. The data from three independent experiments are given as the mean ± SD (*P < 0.05).
